摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Formyl-1-(trifluoromethyl)cyclopentane | 371917-30-5

中文名称
——
中文别名
——
英文名称
1-Formyl-1-(trifluoromethyl)cyclopentane
英文别名
1-(Trifluoromethyl)cyclopentanecarbaldehyde;1-(trifluoromethyl)cyclopentane-1-carbaldehyde
1-Formyl-1-(trifluoromethyl)cyclopentane化学式
CAS
371917-30-5
化学式
C7H9F3O
mdl
——
分子量
166.143
InChiKey
NODWEWSZMABMOW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-Formyl-1-(trifluoromethyl)cyclopentane 在 sulfur tetrafluoride 作用下, 反应 48.0h, 以52%的产率得到1-Difluoromethyl-1-(trifluoromethyl)cyclopentane
    参考文献:
    名称:
    Routes from 1,1-cycloalkanedicarboxylic acids to geminal bis(polyfluoromethyl) substituted carbocycles
    摘要:
    1-Fluoroformyl-1-1(trifluoromethyl)cycloalkanes (1), prepared by treatment of 1,1-cycloalkane-dicarboxylic acids with SF4, were efficiently reduced to 1-hydroxymethyl-1-(trifluoromethyl)-cycloalkanes (2). Routes for the conversion of alcohols 2 to 1-methyl-1-(trifluoromethyl) cycloalkanes (4), 1-fluoromethyl-1-(trifluoromethyl)cycloalkanes (6) and 1-difluoromethyl-1-(trifluoromethyl)cycloalkanes (8), via iodides 3, triflates 5 and aldehydes 7, respectively, were investigated. (C) 2001 Elsevier Science B.V. All rights reserved.
    DOI:
    10.1016/s0022-1139(01)00353-0
  • 作为产物:
    描述:
    (1-(三氟甲基)环戊基)甲醇吡啶chromium(VI) oxide 作用下, 以 二氯甲烷 为溶剂, 反应 48.0h, 以66%的产率得到1-Formyl-1-(trifluoromethyl)cyclopentane
    参考文献:
    名称:
    Routes from 1,1-cycloalkanedicarboxylic acids to geminal bis(polyfluoromethyl) substituted carbocycles
    摘要:
    1-Fluoroformyl-1-1(trifluoromethyl)cycloalkanes (1), prepared by treatment of 1,1-cycloalkane-dicarboxylic acids with SF4, were efficiently reduced to 1-hydroxymethyl-1-(trifluoromethyl)-cycloalkanes (2). Routes for the conversion of alcohols 2 to 1-methyl-1-(trifluoromethyl) cycloalkanes (4), 1-fluoromethyl-1-(trifluoromethyl)cycloalkanes (6) and 1-difluoromethyl-1-(trifluoromethyl)cycloalkanes (8), via iodides 3, triflates 5 and aldehydes 7, respectively, were investigated. (C) 2001 Elsevier Science B.V. All rights reserved.
    DOI:
    10.1016/s0022-1139(01)00353-0
点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed Selective Reduction of Carboxylic Acids to Aldehydes
    作者:Andrei V. Iosub、Štefan Moravčík、Carl-Johan Wallentin、Joakim Bergman
    DOI:10.1021/acs.orglett.9b02779
    日期:2019.10.4
    The direct reduction of carboxylic acids to aldehydes is a fundamental transformation in organic synthesis. The combination of an air-stable Ni precatalyst, dimethyl dicarbonate as an activator, and silane reductant effects this reduction for a wide variety of substrates, including pharmaceutically relevant structures, in good yields and with no overreduction to alcohols. Moreover, this methodology
    羧酸直接还原为醛是有机合成中的基本转变。空气稳定的Ni预催化剂,作为活化剂的二碳酸二甲酯硅烷还原剂的结合可有效降低多种底物(包括药学上相关的结构)的收率,并且不会过度还原成醇。而且,该方法学是可扩展的,允许获得代醛,并且还与一锅使用醛产品兼容。
  • [EN] NECROSIS INHIBITORS<br/>[FR] INHIBITEURS DE NÉCROSE
    申请人:NAT INST OF BIOLOG SCIENCES BEIJING
    公开号:WO2016101887A1
    公开(公告)日:2016-06-30
    The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
    该发明提供了抑制细胞坏死和/或人类受体相互作用蛋白1激酶(RIP1)的酰胺,包括相应的磺酰胺,以及其药用盐、氢化物和立体异构体。这些化合物用于制备药物组合物,并用于制备方法,包括用有效量的化合物或组合物治疗需要的人,并检测人的健康或状况的改善。
  • NECROSIS INHIBITORS
    申请人:National Institute Of Biological Sciences, Beijing
    公开号:EP3224245A1
    公开(公告)日:2017-10-04
  • MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
    申请人:Crinetics Pharmaceuticals, Inc.
    公开号:EP3802500A1
    公开(公告)日:2021-04-14
查看更多